A new investment fund dedicated to the cannabinoid healthcare
market has been launched in Guernsey.
Verdite Capital Fund I, promoted by Chrystal Capital Partners,
is the first to have been approved by the Guernsey Financial
Services Commission. The fund has been described as
Europe's largest dedicated fund in the sector, is reported to
be looking to raise £100 million in a first fundraising and
to double that in a later second raise.
The fund will seek returns through a diversified portfolio in
this non-correlated rapidly growing sector. It will invest in
companies across the value chain of the legal cannabinoid market
globally.
Chrystal Capital Partners considered five
leading international finance centres for the fund's domicile
and chose Guernsey. It said it favoured the island due to its
stable, secure and well-regulated investment and finance
industry.
